Advertisement

Topics

Independence Holding Company Announces 32% Increase in 2015 Second-Quarter Results and 37% Increase in Six-Month Results

20:00 EDT 5 Aug 2015 | Globe Newswire

STAMFORD, Conn., Aug. 06, 2015 (GLOBE NEWSWIRE) -- Independence Holding Company (NYSE:IHC) today reported 2015 second-quarter and six-month results.    

Financial Results

Net income attributable to IHC increased 32% to $.29 per share, diluted, or $5,032,000, for the three months ended June 30, 2015 compared to $.22 per share, diluted, or $3,848,000, for the three months ended June 30, 2014. Net income attributable to IHC increased 37% to $.59 per share, diluted, or $10,251,000, for the six months ended June 30, 2015 compared to $.43 per share, diluted, or $7,549,000, for the six months ended June 30, 2014.

Revenues decreased $2,914,000 to $133,105,000 for the three months ended June 30, 2015 compared to revenues for the three months ended June 30, 2014. Revenues decreased $9,721,000 to $267,370,000 for the six months ended June 30, 2015 compared to revenues for the six months ended June 30, 2014. The decrease in revenues is primarily due to the runoff of major medical premiums from lines that we exited largely as a result of the requirements of the Affordable Care Act (“ACA”) and amounted to $12,912,000 for the second quarter and $31,699,000 for the first six months of 2014, offset in part by an increase in medical stop-loss and specialty health premiums.

Chief Executive Officer’s Comments

Roy T. K. Thung, Chief Executive Officer, commented, “Our significant earnings increase in the current quarter and for the six months was largely driven by continued growth in earned premium and significantly increased earnings from our direct medical stop-loss and group life, disability and DBL lines of business, and increased earnings from our specialty health line of business.  We continue to see strong growth in our direct written stop loss business, increasing 38% in the twelve months ended July 2015. This growth has been driven by increased persistency and strong sales as a result of our industry leading suite of product features and options as well as solutions, such as our group captive model, that respond to the emerging needs of small and medium size employers.   The Company currently has $285 million in direct in-force gross premiums and is expected to exceed $300 million by the end of 2015. Our disciplined underwriting approach has resulted in consistent underwriting margins, thus producing a growing contribution to net income. Our earnings were also positively impacted by our specialty health business, which grew significantly and has produced very positive profit margins in 2015.  Our earnings should also reflect an immediate increase as a result of Madison National Life (MNL) and Standard Security Life completing the reinsurance of substantially all of their run-off blocks of individual life and annuities and the sale of MNL’s infrastructure related to those blocks for an aggregate purchase price of $42 million.

Despite a significant increase in premiums for the products we are currently selling, exiting major medical has negatively impacted our revenues for the first six months, although this impact will lessen over future quarters.  We believe the proposed mergers of four of the largest health insurers and the exit of another significant player from the individual and certain specialty lines will create significant opportunities for our niche products, including short term medical and small group self-funding.  The consolidation of traditional health insurers will create tremendous growth in health payer systems offering their own insurance products. We are confident that our fully insured national administrator can utilize its advanced IT platform to be a market leader in providing solutions to these payer systems.

Our overall investment portfolio continues to be very highly rated (on average, AA) and has a duration of approximately six years. Our book value increased to $17.13 per share at June 30, 2015 from $16.76 per share at December 31, 2014, and our total stockholders’ equity increased to $297 million at June 30, 2015 compared to $291 million at December 31, 2014.”  

About Independence Holding Company

Independence Holding Company is a holding company principally engaged in the life and health insurance business, and the acquisition of blocks of policies, through its insurance company subsidiaries (Standard Security Life Insurance Company of New York, Madison National Life Insurance Company, Inc. and Independence American Insurance Company) and its marketing and administrative affiliates.  Standard Security Life furnishes medical stop-loss, group major and limited medical, short-term medical, group long-term and short-term disability, group life, short-term, employer-mandatory disability benefit policies in New York, group and individual dental, vision and various supplemental products.  Madison National Life sells group life and disability, group limited medical, group and individual dental, individual life insurance and various supplemental products.  Independence American offers pet insurance, non-subscriber occupational accident, short-term medical, medical stop-loss, group and individual dental and various supplemental products.  IHC owns certain subsidiaries through its majority ownership of American Independence Corp. (NASDAQ:AMIC), which is a holding company principally engaged in the insurance and reinsurance business.

Forward-looking Statements

Certain statements and information contained in this release may be considered “forward-looking statements,” such as statements relating to management's views with respect to future events and financial performance.  Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from historical experience or from future results expressed or implied by such forward-looking statements.  Potential risks and uncertainties include, but are not limited to, economic conditions in the markets in which IHC operates, new federal or state governmental regulation, IHC’s ability to effectively operate, integrate and leverage any past or future strategic acquisition, and other factors which can be found in IHC’s other news releases and filings with the Securities and Exchange Commission.  IHC expressly disclaims any duty to update its forward-looking statements unless required by applicable law.”

INDEPENDENCE HOLDING COMPANY
 
SECOND QUARTER REPORT
June 30, 2015
(In Thousands, Except Per Share Data)
      
  Three Months Ended  Six Months Ended
  June 30,  June 30,
   2015  2014  2015 2014 
            
REVENUES:           
Premiums earned$ 120,443 $  121,135  $242,557$  244,405  
Net investment income  4,505    5,434   9,946   11,235  
Fee income  4,487    3,861   8,203   13,200  
Other income  1,570    1,070   2,564   2,181  
Net realized investment gains  2,100    4,519   4,100   6,070  
            
   133,105    136,019   267,370   277,091 
            
EXPENSES:           
Insurance benefits, claims and reserves  79,380    83,263   159,000   168,572 
Selling, general and administrative expenses  43,702    44,947   87,851   93,082 
Amortization of deferred acquisitions costs  1,424    1,189   2,888   2,471 
Interest expense on debt  478    337   910   818 
            
   124,984    129,736   250,649   264,943 
            
Income before income taxes  8,121    6,283   16,721   12,148  
Income taxes  2,965    2,403   6,234   4,263  
            
Net income   5,156    3,880   10,487   7,885  
Less: income from noncontrolling interests           
 in subsidiaries    (124)   (32)    (236)  (336)
            
NET INCOME ATTRIBUTABLE TO IHC$ 5,032 $  3,848  $10,251$  7,549  
            
Basic income per common share$.29 $  .22 $.59$  .43  
            
WEIGHTED AVERAGE SHARES OUTSTANDING  17,338    17,485   17,351   17,553  
            
Diluted income per common share$.29 $  .22 $.59$  .43  
            
WEIGHTED AVERAGE DILUTED SHARES           
 OUTSTANDING  17,501     17,657      17,516   17,709  
              
As of August 1, 2015, there were 17,299,351 common shares outstanding, net of treasury shares.


INDEPENDENCE HOLDING COMPANY
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Share Data)
     
  June 30, December 31,
   2015  2014 
     
ASSETS:    
 Investments:    
 Short-term investments$ 50 $50  
 Securities purchased under agreements to resell  23,429  16,790  
 Trading securities  9,242  11,095  
 Fixed maturities, available-for-sale  608,256  583,880  
 Equity securities, available-for-sale  9,051  13,895  
 Other investments  23,745  25,251  
 Total investments  673,773  650,961  
     
 Cash and cash equivalents  23,547  25,083  
 Deferred acquisition costs  31,767  30,806  
 Due and unpaid premiums  66,473  62,628  
 Due from reinsurers  266,597  278,242  
 Premium and claim funds  33,061  32,553  
 Goodwill  56,452  50,318  
 Other assets  51,533  57,126  
     
 TOTAL ASSETS$ 1,203,203 $1,187,717  
     
LIABILITIES AND STOCKHOLDERS’ EQUITY:    
LIABILITIES:    
 Policy benefits and claims$ 249,556 $236,803  
 Future policy benefits  275,501  277,041  
 Funds on deposit  181,307  186,782  
 Unearned premiums  12,176  9,455  
 Other policyholders' funds  17,637  18,802  
 Due to reinsurers  49,067  47,945  
 Accounts payable, accruals and other liabilities  65,516  67,641  
 Debt  8,326  4,000  
 Junior subordinated debt securities  38,146  38,146  
     
 TOTAL LIABILITIES  897,232  886,615  
     
STOCKHOLDERS’ EQUITY:    
IHC STOCKHOLDERS' EQUITY:    
 Preferred stock (none issued)    -  
 Common stock  18,553  18,531  
 Paid-in capital  127,451  127,098  
 Accumulated other comprehensive income  (3,217) 22  
 Treasury stock, at cost  (12,880) (12,141)
 Retained earnings  167,092  157,667  
     
TOTAL IHC STOCKHOLDERS’ EQUITY  296,999  291,177  
NONCONTROLLING INTERESTS IN SUBSIDIARIES  8,972  9,925  
      
 TOTAL EQUITY  305,971  301,102  
      
 TOTAL LIABILITIES AND EQUITY $ 1,203,203 $1,187,717  

 

Loan Nisser
(646) 509-2107
www.IHCGroup.com
NEXT ARTICLE

More From BioPortfolio on "Independence Holding Company Announces 32% Increase in 2015 Second-Quarter Results and 37% Increase in Six-Month Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...